Literature DB >> 6767400

Nitroglycerin compatibility with intravenous fluid filters, containers, and administration sets.

D M Baaske, A H Amann, D M Wagenknecht, M Mooers, J E Carter, H J Hoyt, R G Stoll.   

Abstract

The effect of intravenous filters, containers and administration sets on nitroglycerin potency was studied. Solutions of nitroglycerin (50 and 100 microgram/ml) in water for injection, in 5% dextrose injection and in 0.9% sodium chloride injection were prepared. The concentration of these solutions was measured after (1) filtration through a 0.2-micron filter, (2) storage in glass and plastic containers and (3) administration through eight i.v. administration sets. Filters decreased nitroglycerin concentration by 2--55%. Nitroglycerin concentration was not changed after storage for 48 hours in glass bottles. In plastic i.v. bags, concentration decreases were substantial and related to surface contact area and storage temperature. The i.v. administration sets caused immediate, substantial decreases in nitroglycerin concentration that were a function of drip rate, surface area, length of exposure to tubing, and tubing materials. The study suggests that concentrations of nitroglycerin solutions could be reduced by as much as 80% when filtered, placed in a plastic i.v. bag and given through an i.v. administration set.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6767400

Source DB:  PubMed          Journal:  Am J Hosp Pharm        ISSN: 0002-9289


  9 in total

1.  Determination of solute-polymer interaction properties and their application to parenteral product container compatibility evaluations.

Authors:  R A Kenley; D R Jenke
Journal:  Pharm Res       Date:  1990-09       Impact factor: 4.200

2.  On-line measurement of nitric oxide release from organic nitrates in the intact coronary circulation.

Authors:  K Schrör; S Förster; I Woditsch
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1991-08       Impact factor: 3.000

3.  The release of nitroglycerin absorbed into the central venous catheter.

Authors:  K Akiyama; J Hirota; M Takiguchi; S Ohsawa; A Hashimoto
Journal:  Surg Today       Date:  1997       Impact factor: 2.549

4.  Delivery systems for intravenous nitroglycerin.

Authors:  W A Mutch; I R Thomson
Journal:  Can Anaesth Soc J       Date:  1983-01

5.  Plasma concentrations and haemodynamic effects of nitroglycerin during and after intravenous infusion in healthy volunteers.

Authors:  P R Imhof; A Sieber; J Hodler; P Müller; B Ott; P Fankhauser; L C Chu; A Gérardin
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

6.  Influence of ethanol on the delivery of intravenous nitroglycerin solutions.

Authors:  R Leor; M Feinstein; M H Luria; C Hod; B Rabinowitz
Journal:  Eur J Clin Pharmacol       Date:  1989       Impact factor: 2.953

Review 7.  Intravenous glyceryl trinitrate (nitroglycerin). A review of its pharmacological properties and therapeutic efficacy.

Authors:  E M Sorkin; R N Brogden; J A Romankiewicz
Journal:  Drugs       Date:  1984-01       Impact factor: 9.546

8.  Pharmacokinetics and pharmacodynamics of nitroglycerin and its dinitrate metabolites in conscious dogs: intravenous infusion studies.

Authors:  F W Lee; T Salmonson; L Z Benet
Journal:  J Pharmacokinet Biopharm       Date:  1993-10

9.  Nitroglycerin stimulates synthesis of prostacyclin by cultured human endothelial cells.

Authors:  R I Levin; E A Jaffe; B B Weksler; K Tack-Goldman
Journal:  J Clin Invest       Date:  1981-03       Impact factor: 14.808

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.